Showing 105 results

Filters Content type: News, Editors' picks, About HIV Topic: Treatment simplification strategies

Research into HIV treatment strategies in which the number of antiretroviral drugs or frequency of dosing is reduced. Some dual therapy regimens have proven to be safe and effective.

HIV treatment

Dovato Factsheet

About HIV
April 2021
HIV treatment

Dovato Detailed information

About HIV
April 2021
Treatment simplification strategies

Four-days-on, three-days-off treatment regimen still looks effective after two years

News
16 March 2021
Treatment simplification strategies

Similar rate of severe clinical outcomes with two drug vs three drug HIV treatment combinations

News
17 February 2021
New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Starting treatment

Dovato Shows Promise as a Rapid Test-and-Treat HIV Regimen

Editor's pick
POZ
1 September 2020
Treatment simplification strategies

As Two-Drug HIV Treatment Rises, Long-Term Inflammation Becomes a Potential Concern

Editor's pick
TheBodyPro
8 July 2020
Injectable & long-acting HIV treatment

Long-acting injectables might be administered every two months

News
11 March 2020
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Treatment simplification strategies

Options for two-drug simplification expand

News
14 November 2019
Treatment simplification strategies

Jitters Over New Two-Drug HIV Regimens

Editor's pick
Medscape (requires free registration)
12 November 2019
Low CD4 count

Two-Drug HIV Regimen Works Well Except in People With Low CD4 Count, Study Finds

Editor's pick
TheBodyPro
22 October 2019
Treatment simplification strategies

Some issues to consider with Dovato (dolutegravir + 3TC)

Editor's pick
CATIE
3 October 2019
Treatment simplification strategies

Dolutegravir dual therapy works well for both first line and maintenance treatment

News
29 July 2019
New & experimental HIV treatments

Islatravir plus doravirine may offer new dual therapy option

News
25 July 2019
Treatment simplification strategies

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds

News
25 July 2019
Pharmaceutical industry

Can new Dovato data jump-start uptake of 2-drug HIV regimen? ViiV hopes so

Editor's pick
FiercePharma
24 July 2019
Cardiovascular disease

Efavirenz Dose Reduction Improves Lipid Profile in Adults With HIV-1

Editor's pick
Infectious Disease Advisor
19 June 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

Editor's pick
ViiV press release
5 April 2019
Treatment simplification strategies

Viral suppression maintained with alternate-day dosing of efavirenz/tenofovir/emtricitabine

News
1 April 2019
Treatment simplification strategies

Two-antiretroviral maintenance failure - raltegravir regimens seem most vulnerable

Editor's pick
NATAP
29 March 2019